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of auto-regulation caused by severe hypertension or direct toxic insult to endothelium is the most popular theory for pathophysiology (Bartynski, 2008b; Dinsdale, 1983; Schwartz et al., 1995; Strandgaard, Olesen, Skinhoj, & Lassen, 1973) . One of the unsettled questions about PRES is the correlation between the brain lesion distribution patterns and blood pressure (BP). The aim of this study is to identify the relationship between brain lesion distribution patterns and BP.
| ME THODS

| Data collection
We investigated patients with PRES who were admitted to Severance Hospital between January 2001 and December 2014. All patients had been admitted already at least 24 hr before the symptom onset.
Diagnosis of PRES was based on clinical features (predisposing conditions, headache, seizures, mental alteration, and visual disturbances); multifocal lesions on MRI, mainly suggesting vasogenic edema; clinical recovery; and when available, reversibility of MRI lesions. Clinical information such as past medical histories, comorbid illnesses, brain magnetic resonance imaging (MRI), BP measured 1 day before the symptom onset (pre-BP), and BP checked (onset-BP) at symptom onset (mental alteration, seizure, severe headache, or visual disturbances) was collected. BP had been measured every at least 8 hr. BP measured between 24 and 32 hr before the symptom onset was regarded as BP 1 day before the symptom onset.
Mean arterial pressure (MAP) was calculated using the formula:
Mean arterial pressure = 2/3 diastolic BP + 1/3 systolic BP.
Cases with unclear symptom onset, without BP documentation, without brain MRI, with pre-existing neurologic deficits, or with a history of seizure disorder were excluded. As a result, 65 patients were selected. This study was approved by the Institutional Review Board of Severance Hospital.
| Brain imaging and brain lesion distribution
Brain MRI using either 1.5-T (Signa Horizon, GE Medical System, Milwaukee, WI, or Gyroscan Intera, Philips Medical Systems, Best, The Netherlands) or 3.0-T scanner (Achieva, Philips Medical Systems, Best, The Netherlands), including conventional spin-echo T 1 -weighted axial, T 2 -weighted axial, and fluid-attenuated inversion recovery axial sequences, were commonly reviewed in all the patients. The mean time to the MRI evaluation was 1.6 days (range, 0-6 days).
The lesion distribution of the PRES was determined by one ex- 
| Statistical analysis
Statistical analysis was performed using SPSS (version 20) for Windows (IBM Corp., Armonk, NY, USA). The Chi-square, MannWhitney U, Spearman's correlation, and Kruskal-Wallis tests were used to determine the statistical significance (p < 0.05). (Table 1 ). Multiple medical conditions were found in 12 patients of 65. Visual disturbances including blurred vision, hemianopsia, hallucination, and cortical blindness were present in 31 patients (47.7%), headache was present in 42 (64.6%), seizure was present in 51 (78.5%), limb weakness was present in 7 (10.8%), and mental alteration was found in 36 (55.4%) of 65 patients. of 65 patients. There was no significant relationship between the medical condition and the specific brain region preference except for the BG involvement in patients with preeclampsia-eclampsia.
| Brain lesion distribution
Five of 10 patients with preeclampsia-eclampsia had lesions in BG (p = 0.010).
| Relationship among lesion distribution, BP, and etiology
The mean time of BP measurement before the symptom onset was 27.2 ± 2.5 hr (range, 24-31 hr). The mean MAP was 99.7 ± 13.8 mmHg (range, 73.3-133. 3 mmHg) at the presymptomatic period and 133.0 ± 21.2 mmHg (range, 81.3-183.3 mmHg) at the symptom onset in the total patients. The onset-MAP was significantly higher than pre-MAP (p < 0.001). In the brain lesion scoring, the mean LSP was 7.1 ± 3.1 (range, 1-14) in the total patients Patients were classified by underlying medical conditions and the mean pre-MAP, onset-MAP, and LSP were calculated. There were no significant differences in pre-MAP, onset-MAP, and LSP according to medical conditions (Table 3) .
| D ISCUSS I ON
In this study, we assumed an evolution period before the toxic symptom onset. We collected the BP profiles in the presymptomatic and onset periods, and compared lesion distribution with BPs. As Renal failure (n = 22) 102.2 ± 16.3 138.9 ± 21.9 7.5 ± 3.4
Preeclampsia-eclampsia (n = 10) 100.2 ± 11.7 127.3 ± 12.4 7.6 ± 2.5
Autoimmune disease (n = 9) 96.6 ± 11.7 129.8 ± 18.2 7.4 ± 2.4
Hypertension (n = 4) 116.8 ± 11.6 140.0 ± 11.5 4.8 ± 2.5
Others (n = 6) 93.2 ± 2.2 129.0 ± 25.2 4.3 ± 2.6
Note. CTx-IS, Chemotherapy-immunosuppression; LSP, lesion scoring point.
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within the PRES cases, their result seems to be contrary to our result showing the significant BP elevation at the symptom onset compared with the presymptomatic period.
To our knowledge, the relationship between PRES severity and pre-BP has not been investigated. It is interesting that LSP as a marker of PRES severity was explained better by pre-BP rather than onset-BP. In the Doppler study for pre-eclampsia patients who were neurologically normal, their autoregulation indices were lower than those of healthy controls, suggesting dysfunctional autoregulation during presymptomatic period (van Veen et al., 2013) . Therefore, we presume that higher BP during presymptomatic period may make worse the impairment of cerebral autoregulation and may lead to more severe PRES. BP elevation during presymptomatic period might be a heralding sign of impending PRES or an important factor affecting the severity of PRES although BP was not investigated at earlier time points. Prompt control of a rising BP would be required for the prevention of PRES in patients with risk factors for PRES.
Our study has limitations. First, there may be limitations in the detection of clinical symptoms and the estimation of onset time because of a retrospective analysis depending on the accuracy of medical records. Second, the severity of edematous lesion was not evaluated in our study. Only the lesion distribution could not reflect lesion severity appropriately. Higher pre-BP may be more likely associated with the number of affected brain regions rather than with disease severity. Third, the required evolution period for the PRES generation may differ between individuals. Thus, the information about BP at multiple time points before the toxic symptom onset is required to investigate the preclinical hemodynamic changes of PRES. Fourth, this study included only hospitalized patients, which may produce selection bias. Also, a small number of patients prevent to reveal the relationship between etiologies and lesion distribution patterns. Above all, BP is not the sole controlling factor for cerebral autoregulation. Considering the above limitations, a cautious interpretation of the study results is needed.
| CON CLUS ION
This study may suggest that the patients with PRES who had higher BP in the presymptomatic period might be more likely to show wider spatial distribution of edematous lesions.
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